AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Gastrointest Liver Physiol 262: G274-G277, 1992;
0193-1857/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sieber, C. C.
Right arrow Articles by Groszmann, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sieber, C. C.
Right arrow Articles by Groszmann, R. J.

AJP - Gastrointestinal and Liver Physiology, Vol 262, Issue 2 274-G277, Copyright © 1992 by American Physiological Society

ARTICLES

Effect of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats

C. C. Sieber, P. G. Mosca and R. J. Groszmann
Hepatic Hemodynamic Laboratory, Veterans Administration Medical Center, West Haven, Connecticut.

Vasoactive effects of natural somatostatin (SRIF-14) and its analogue octreotide were studied in in vitro perfused superior mesenteric arterial beds of normal (Sham) and portal hypertensive (PVL) rats. Tested concentrations covered the whole range used in clinical settings (10(-10) to 10(-5) M for SRIF-14 and 10(-11) to 10(-6) M for octreotide, respectively). Vessel resistances only minimally changed to infusions of SRIF-14 (from 3.5 +/- 0.4 to 3.7 +/- 0.5 mmHg.ml-1.min and 3.8 +/- 0.3 to 3.9 +/- 0.4 mmHg.ml-1.min for PVL and Sham) and octreotide (from 3.3 +/- 0.2 to 3.4 +/- 0.4 mmHg.ml-1.min and 3.8 +/- 0.4 to 4.0 42- 0.4 mmHg.ml-1.min for PVL and Sham). The same was true for bolus injections. In contrast, norepinephrine induced significant increases in vessel resistance (up to 110.6 +/- 20.1 mmHg.ml-1.min). In conclusion, SRIF-14 and octreotide exert no direct effect on vascular smooth muscle tone in splanchnic resistance vessels of Sham and PVL rats. The vasoconstriction reported in vivo seems therefore probably mediated by the ability of these peptides to inhibit the secretion of vasodilatatory substances.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y.-Y. Yang, H.-C. Lin, Y.-T. Huang, T.-Y. Lee, W.-C. Lee, M.-C. Hou, F.-Y. Lee, F.-Y. Chang, and S.-D. Lee
Adaptive vasodilatory response after octreotide treatment
Am J Physiol Gastrointest Liver Physiol, July 1, 2001; 281(1): G117 - G123.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
F Junquera, J C Lopez-Talavera, F Mearin, E Saperas, S Videla, J-R Armengol, R Esteban, and J-R Malagelada
Somatostatin plus isosorbide 5-mononitrate versus somatostatin in the control of acute gastro-oesophageal variceal bleeding: a double blind, randomised, placebo controlled clinical trial
Gut, January 1, 2000; 46(1): 127 - 132.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. Kagstrom, C. Olsson, M. Axelsson, and C. E. Franklin
Peptidergic control of gastrointestinal blood flow in the estuarine crocodile, Crocodylus porosus
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 1998; 274(6): R1740 - R1750.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. M. Schwartz, D. deBlois, and E. R. M. O'Brien
The Intima : Soil for Atherosclerosis and Restenosis
Circ. Res., September 1, 1995; 77(3): 445 - 465.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online